当前，疫情没有缓解的趋势，且是愈演愈烈，单日新增确诊达22万多，累计确证1100万人，累计死亡53万人，美洲、非洲以及亚洲疫情都有上升趋势，主要集中在美国、巴西、印度和南非，7月4日新增分别为4.52万，3.79万，2.48万，1.08万。疫苗研究也在紧锣密鼓开展中，目前我们国家病毒研究所已经开展了三期临床试验，期待会有好结果,早日取得抗疫最终胜利，造福世界黎民百姓,现基于Web of science对研究情况进行简要陈列，以供大家参考！ 

 一、刊文及引用统计 

刊文国家情况

刊文数量前15的作者

所刊登文献的使用的语言种类

刊文机构名称及刊文数量

刊文的主要分类

刊文主要期刊名称及刊文数量

刊文文献类型

刊文的研究方向

CNS及柳叶刀刊文统计情况

CNS及柳叶刀刊文论文明细

1.SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor

作者: Hoffmann, Markus; Kleine-Weber, Hannah; Schroeder, Simon; 等.

CELL   卷: ‏ 181   期: ‏ 2   页: ‏ 271-+   出版年: ‏ APR 16 2020

被引频次: 344

2.Nowcasting and forecasting the potential domestic and international spread of the 2019-nCoV outbreak originating in Wuhan, China: a modelling study

作者: Wu, Joseph T.; Leung, Kathy; Leung, Gabriel M.

LANCET   卷: ‏ 395   期: ‏ 10225   页: ‏ 689-697   出版年: ‏ FEB 29 2020

被引频次: 267

3.Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation

作者: Wrapp, Daniel; Wang, Nianshuang; Corbett, Kizzmekia S.; 等.

SCIENCE   卷: ‏ 367   期: ‏ 6483   页: ‏ 1260-+   出版年: ‏ MAR 13 2020

被引频次: 255

4.Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury

作者: Russell, Clark D.; Millar, Jonathan E.; Baillie, J. Kenneth

LANCET   卷: ‏ 395   期: ‏ 10223   页: ‏ 473-475   出版年: ‏ FEB 15 2020

被引频次: 205

5.Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein

作者: Walls, Alexandra C.; Park, Young-Jun; Tortorici, M. Alejandra; 等.

CELL   卷: ‏ 181   期: ‏ 2   页: ‏ 281-+   出版年: ‏ APR 16 2020

被引频次: 128

6.Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2

作者: Yan, Renhong; Zhang, Yuanyuan; Li, Yaning; 等.

SCIENCE   卷: ‏ 367   期: ‏ 6485   页: ‏ 1444-+   出版年: ‏ MAR 27 2020

被引频次: 109

7.Substantial undocumented infection facilitates the rapid dissemination of novel coronavirus (SARS-CoV-2)

作者: Li, Ruiyun; Pei, Sen; Chen, Bin; 等.

SCIENCE   卷: ‏ 368   期: ‏ 6490   页: ‏ 489-+   出版年: ‏ MAY 1 2020

被引频次: 108

8.2019-nCoV transmission through the ocular surface must not be ignored

作者: Lu, Cheng-wei; Liu, Xiu-fen; Jia, Zhi-fang

LANCET   卷: ‏ 395   期: ‏ 10224   页: ‏ E39-E39   出版年: ‏ FEB 22 2020

被引频次: 85

9.Baricitinib as potential treatment for 2019-nCoV acute respiratory disease

作者: Richardson, Peter; Griffin, Ivan; Tucker, Catherine; 等.

LANCET   卷: ‏ 395   期: ‏ 10223   页: ‏ E30-E31   出版年: ‏ FEB 15 2020

被引频次: 83

10.On the use of corticosteroids for 2019-nCoV pneumonia

作者: Shang, Lianhan; Zhao, Jianping; Hu, Yi; 等.

LANCET   卷: ‏ 395   期: ‏ 10225   页: ‏ 683-684   出版年: ‏ FEB 29 2020

被引频次: 50

11.Reducing mortality from 2019-nCoV: host-directed therapies should be an option

作者: Zumla, Alimuddin; Hui, David S.; Azhar, Esam I.; 等.

LANCET   卷: ‏ 395   期: ‏ 10224   页: ‏ E35-E36   出版年: ‏ FEB 22 2020

被引频次: 45

12.Emerging understandings of 2019-nCoV

作者: [Anonymous]

LANCET   卷: ‏ 395   期: ‏ 10221   页: ‏ 311-311   出版年: ‏ FEB 1 2020

被引频次: 42

13.Projecting the transmission dynamics of SARS-CoV-2 through the postpandemic period

作者: Kissler, Stephen M.; Tedijanto, Christine; Goldstein, Edward; 等.

SCIENCE   卷: ‏ 368   期: ‏ 6493   页: ‏ 860-+   出版年: ‏ MAY 22 2020

被引频次: 41

14.Structural basis of receptor recognition by SARS-CoV-2

作者: Shang, Jian; Ye, Gang; Shi, Ke; 等.

NATURE   卷: ‏ 581   期: ‏ 7807   页: ‏ 221-+   出版年: ‏ MAY 2020

被引频次: 38

15.Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved alpha-ketoamide inhibitors

作者: Zhang, Linlin; Lin, Daizong; Sun, Xinyuanyuan; 等.

SCIENCE   卷: ‏ 368   期: ‏ 6489   页: ‏ 409-+   出版年: ‏ APR 24 2020

被引频次: 37

16.Inhibition of SARS-CoV-2 Infections in Engineered Human Tissues Using Clinical-Grade Soluble Human ACE2

作者: Monteil, Vanessa; Kwon, Hyesoo; Prado, Patricia; 等.

CELL   卷: ‏ 181   期: ‏ 4   页: ‏ 905-+   出版年: ‏ MAY 14 2020

被引频次: 36

17.Identifying SARS-CoV-2-related coronaviruses in Malayan pangolins

作者: Lam, Tommy Tsan-Yuk; Jia, Na; Zhang, Ya-Wei; 等.

NATURE     

被引频次: 36

18.2019-nCoV epidemic: address mental health care to empower society

作者: Bao, Yanping; Sun, Yankun; Meng, Shiqiu; 等.

LANCET   卷: ‏ 395   期: ‏ 10224   页: ‏ E37-E38   出版年: ‏ FEB 22 2020

被引频次: 34

19.Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor

作者: Lan, Jun; Ge, Jiwan; Yu, Jinfang; 等.

NATURE   卷: ‏ 581   期: ‏ 7807   页: ‏ 215-+   出版年: ‏ MAY 2020

被引频次: 33

20.What to do next to control the 2019-nCoV epidemic?

作者: Wang, Fu-Sheng; Zhang, Chao

LANCET   卷: ‏ 395   期: ‏ 10222   页: ‏ 391-393   出版年: ‏ FEB 8 2020

被引频次: 32

21.Quantifying SARS-CoV-2 transmission suggests epidemic control with digital contact tracing

作者: Ferretti, Luca; Wymant, Chris; Kendall, Michelle; 等.

SCIENCE   卷: ‏ 368   期: ‏ 6491   特刊: ‏ SI   页: ‏ 619-+   出版年: ‏ MAY 8 2020

被引频次: 28

22.Developing antibody tests for SARS-CoV-2

作者: Petherick, Anna

LANCET   卷: ‏ 395   期: ‏ 10230   页: ‏ 1101-1102   出版年: ‏ APR 4 2020

被引频次: 21

23.2019-nCoV epidemic: what about pregnancies?

作者: Favre, Guillaume; Pomar, Leo; Musso, Didier; 等.

LANCET   卷: ‏ 395   期: ‏ 10224   页: ‏ E40-E40   出版年: ‏ FEB 22 2020

被引频次: 20

24.A highly conserved cryptic epitope in the receptor binding domains of SARS-CoV-2 and SARS-CoV

作者: Yuan, Meng; Wu, Nicholas C.; Zhu, Xueyong; 等.

SCIENCE   卷: ‏ 368   期: ‏ 6491   特刊: ‏ SI   页: ‏ 630-+   出版年: ‏ MAY 8 2020

被引频次: 19

25.An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV-2 epidemic: an observational cohort study

作者: Verdoni, Lucio; Mazza, Angelo; Gervasoni, Annalisa; 等.

LANCET   卷: ‏ 395   期: ‏ 10239   页: ‏ 1771-1778   出版年: ‏ JUN 6 2020

被引频次: 17

26.Structure of M-pro from SARS-CoV-2 and discovery of its inhibitors

作者: Jin, Zhenming; Du, Xiaoyu; Xu, Yechun; 等.

NATURE   卷: ‏ 582   期: ‏ 7811   页: ‏ 289-+   出版年: ‏ JUN 2020

被引频次: 16

27.SARS-CoV-2 Receptor ACE2 Is an Interferon-Stimulated Gene in Human Airway Epithelial Cells and Is Detected in Specific Cell Subsets across Tissues

作者: Ziegler, Carly G. K.; Allon, Samuel J.; Nyquist, Sarah K.; 等.

团体作者: HCA Lung Biol Network

CELL   卷: ‏ 181   期: ‏ 5   页: ‏ 1016-+   出版年: ‏ MAY 28 2020

被引频次: 15

28.2019-nCoV, fake news, and racism

作者: Shimizu, Kazuki

LANCET   卷: ‏ 395   期: ‏ 10225   页: ‏ 685-686   出版年: ‏ FEB 29 2020

被引频次: 15

29.First known person-to-person transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in the USA

作者: Ghinai, Isaac; McPherson, Tristan D.; Hunter, Jennifer C.; 等.

团体作者: Illinois COVID-19 Investigation

LANCET   卷: ‏ 395   期: ‏ 10230   页: ‏ 1137-1144   出版年: ‏ APR 4 2020

被引频次: 13

30.SARS-CoV-2 is an appropriate name for the new coronavirus

作者: Wu, Yuntao; Ho, Wenzhe; Huang, Yaowei; 等.

LANCET   卷: ‏ 395   期: ‏ 10228   页: ‏ 949-950   出版年: ‏ MAR 21 2020

被引频次: 13

31.Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19

作者: Blanco-Melo, Daniel; Nilsson-Payant, Benjamin E.; Liu, Wen-Chun; 等.

CELL   卷: ‏ 181   期: ‏ 5   页: ‏ 1036-+   出版年: ‏ MAY 28 2020

被引频次: 12

32.Secondary attack rate and superspreading events for SARS-CoV-2

作者: Liu, Yang; Eggo, Rosalind M.; Kucharski, Adam J.

LANCET   卷: ‏ 395   期: ‏ 10227   页: ‏ E47-E47   出版年: ‏ MAR 14 2020

被引频次: 12

33.A Genomic Perspective on the Origin and Emergence of SARS-CoV-2

作者: Zhang, Yong-Zhen; Holmes, Edward C.

CELL   卷: ‏ 181   期: ‏ 2   页: ‏ 223-227   出版年: ‏ APR 16 2020

被引频次: 10

34.Structural and Functional Basis of SARS-CoV-2 Entry by Using Human ACE2

作者: Wang, Qihui; Zhang, Yanfang; Wu, Lili; 等.

CELL   卷: ‏ 181   期: ‏ 4   页: ‏ 894-+   出版年: ‏ MAY 14 2020

被引频次: 9

35.Aerodynamic analysis of SARS-CoV-2 in two Wuhan hospitals

作者: Liu, Yuan; Ning, Zhi; Chen, Yu; 等.

NATURE     

被引频次: 9

36.Minimise nosocomial spread of 2019-nCoV when treating acute respiratory failure

作者: Cabrini, Luca; Landoni, Giovanni; Zangrillo, Alberto

LANCET   卷: ‏ 395   期: ‏ 10225   页: ‏ 685-685   出版年: ‏ FEB 29 2020

被引频次: 9

37.SARS-CoV-2 and viral sepsis: observations and hypotheses

作者: Li, Hui; Liu, Liang; Zhang, Dingyu; 等.

LANCET   卷: ‏ 395   期: ‏ 10235   页: ‏ 1517-1520   出版年: ‏ MAY 9 2020

被引频次: 8

38.Early lessons from the frontline of the 2019-nCoV outbreak

作者: Zhang, Hong

LANCET   卷: ‏ 395   期: ‏ 10225   页: ‏ 687-687   出版年: ‏ FEB 29 2020

被引频次: 8

39.Offline: 2019-nCoV outbreak-early lessons

作者: Horton, Richard

LANCET   卷: ‏ 395   期: ‏ 10221   页: ‏ 322-322   出版年: ‏ FEB 1 2020

被引频次: 8

40.The Architecture of SARS-CoV-2 Transcriptome

作者: Kim, Dongwan; Lee, Joo-Yeon; Yang, Jeong-Sun; 等.

CELL   卷: ‏ 181   期: ‏ 4   页: ‏ 914-+   出版年: ‏ MAY 14 2020

被引频次: 6

41.A Global Effort to Define the Human Genetics of Protective Immunity to SARS-CoV-2 Infection

作者: Casanova, Jean-Laurent; Su, Helen C.

团体作者: COVID Human Genetic Effort

CELL   卷: ‏ 181   期: ‏ 6   页: ‏ 1194-1199   出版年: ‏ JUN 11 2020

被引频次: 3

42.Genomic Epidemiology of SARS-CoV-2 in Guangdong Province, China

作者: Lu, Jing; du Plessis, Louis; Liu, Zhe; 等.

CELL   卷: ‏ 181   期: ‏ 5   页: ‏ 997-+   出版年: ‏ MAY 28 2020

被引频次: 3

43.Has China faced only a herald wave of SARS-CoV-2?

作者: Flahault, Antoine

LANCET   卷: ‏ 395   期: ‏ 10228   页: ‏ 947-947   出版年: ‏ MAR 21 2020

被引频次: 3

44.Coast-to-Coast Spread of SARS-CoV-2 during the Early Epidemic in the United States

作者: Fauver, Joseph R.; Petrone, Mary E.; Hodcroft, Emma B.; 等.

CELL   卷: ‏ 181   期: ‏ 5   页: ‏ 990-+   出版年: ‏ MAY 28 2020

被引频次: 2

45.Cross-neutralization of SARS-CoV-2 by a human monoclonal SARS-CoV antibody

作者: Pinto, Dora; Park, Young-Jun; Beltramello, Martina; 等.

NATURE     

在线发表日期: MAY 2020

被引频次: 2

46.Rapid reconstruction of SARS-CoV-2 using a synthetic genomics platform

作者: Tran Thi Nhu Thao; Labroussaa, Fabien; Ebert, Nadine; 等.

NATURE     

在线发表日期: MAY 2020

被引频次: 2

47.Anti-Chinese sentiment during the 2019-nCoV outbreak

作者: Chung, Roger Yat-Nork; Li, Minnie Ming

LANCET   卷: ‏ 395   期: ‏ 10225   页: ‏ 686-687   出版年: ‏ FEB 29 2020

被引频次: 2

48.Offline: 2019-nCoV-"A desperate plea"

作者: Horton, Richard

LANCET   卷: ‏ 395   期: ‏ 10222   页: ‏ 400-400   出版年: ‏ FEB 8 2020

被引频次: 2

49.Nowcasting and forecasting the potential domestic and international spread of the 2019-nCoV outbreak originating in Wuhan, China: a modelling study (vol 395, pg 689, 2020)

作者: Wu, J. T.; Leung, K.; Leung, G. M.

LANCET   卷: ‏ 395   期: ‏ 10225   页: ‏ E41-E41   出版年: ‏ FEB 29 2020

被引频次: 1

50.Detection of SARS-CoV-2 in human breastmilk

作者: Gross, Rudiger; Conzelmann, Carina; Mueller, Janis A.; 等.

LANCET   卷: ‏ 395   期: ‏ 10239   页: ‏ 1757-1758   出版年: ‏ JUN 6 2020

被引频次: 0

51.Trained Immunity: a Tool for Reducing Susceptibility to and the Severity of SARS-CoV-2 Infection

作者: Netea, Mihai G.; Giamarellos-Bourboulis, Evangelos J.; Dominguez-Andres, Jorge; 等.

CELL   卷: ‏ 181   期: ‏ 5   页: ‏ 969-977   出版年: ‏ MAY 28 2020

被引频次: 0

52.SARS-CoV-2 and influenza virus co-infection

作者: Cuadrado-Payan, Elena; Montagud-Marrahi, Enrique; Torres-Elorza, Manuel; 等.

LANCET   卷: ‏ 395   期: ‏ 10236   页: ‏ E84-E84   出版年: ‏ MAY 16 2020

被引频次: 0

53.The arrival of SARS-CoV-2 in Venezuela

作者: Paniz-Mondolfi, Alberto E.; Sordillo, Emilia M.; Marquez-Colmenarez, Marilianna C.; 等.

LANCET   卷: ‏ 395   期: ‏ 10236   页: ‏ E85-E86   出版年: ‏ MAY 16 2020

被引频次: 0

54.Development of CRISPR as an Antiviral Strategy to Combat SARS-CoV-2 and Influenza

作者: Abbott, Timothy R.; Dhamdhere, Girija; Liu, Yanxia; 等.

CELL   卷: ‏ 181   期: ‏ 4   页: ‏ 865-+   出版年: ‏ MAY 14 2020

被引频次: 0

55.New Zealand eliminates COVID-19 An aggressive approach has enabled New Zealand to end community transmission of SARS-CoV-2. Sophie Cousins reports.

作者: Cousins, Sophie

LANCET   卷: ‏ 395   期: ‏ 10235   页: ‏ 1474-1474   出版年: ‏ MAY 9 2020

被引频次: 0